2018年至2024年澳大利亚新南威尔士州多中心卫生区内呼吸道合胞病毒的流行病学研究

IF 3 3区 医学 Q1 PATHOLOGY
Zubair Akhtar, Adriana Notaras, Essa Tawfiq, Mohana Kunasekaran, C Raina MacIntyre, William Rawlinson, Gregory J Walker
{"title":"2018年至2024年澳大利亚新南威尔士州多中心卫生区内呼吸道合胞病毒的流行病学研究","authors":"Zubair Akhtar, Adriana Notaras, Essa Tawfiq, Mohana Kunasekaran, C Raina MacIntyre, William Rawlinson, Gregory J Walker","doi":"10.1016/j.pathol.2025.06.011","DOIUrl":null,"url":null,"abstract":"<p><p>Respiratory syncytial virus (RSV) epidemiology in Australia is unclear given recent advances in diagnostic testing, COVID-19 interventions, and under-recognition in older adults. Data are needed to inform new RSV vaccine use. We analysed laboratory data from all viral respiratory reverse transcription quantitative polymerase chain reaction (RT-qPCR) diagnostic tests conducted at New South Wales (NSW) Health Pathology in the South Eastern Sydney and Illawarra Health Service from 2018 to 2024. Panel and descriptive analyses were used to report annual RSV testing and detection by age group, care setting, and co-infection with other respiratory viruses using Stata v.18. Of 370,126 unique episodes tested for RSV, there were 13,293 (3.6%) detections. Public health measures for COVID-19 significantly impacted RSV circulation in 2020, with detections nearly absent in the winter season (June-August) and an off-season epidemic occurring in the summer. Annual testing and detection peaked in 2022 and was considerably higher than in pre-pandemic years (testing 6.3-fold and detection 3.4-fold higher than in 2019, respectively). Across the study period, incidence was highest in children aged <5 years (1,613 per 100,000 population). Among older adults (≥60 years of age), prevalence was 125 per 100,000. Testing was primarily performed in outpatients (71%), of which emergency departments were the most frequent care setting (49%). Of all detections, 2,713 (20.4%) had co-infections, with the most commonly co-detected viruses being rhinovirus (37%) and bocavirus (17%). RSV testing increased from 2022 due to expanded respiratory screening, RSV becoming a notifiable disease, and COVID-19 epidemics. Multiplex RT-qPCR testing increased RSV detection, but testing bias exists, with children tested more than adults. Continued surveillance across age groups is essential to assess the impact of new immunisation strategies.</p>","PeriodicalId":19915,"journal":{"name":"Pathology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiology of respiratory syncytial virus within a New South Wales-based multi-centre health district between 2018 and 2024 in Australia.\",\"authors\":\"Zubair Akhtar, Adriana Notaras, Essa Tawfiq, Mohana Kunasekaran, C Raina MacIntyre, William Rawlinson, Gregory J Walker\",\"doi\":\"10.1016/j.pathol.2025.06.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Respiratory syncytial virus (RSV) epidemiology in Australia is unclear given recent advances in diagnostic testing, COVID-19 interventions, and under-recognition in older adults. Data are needed to inform new RSV vaccine use. We analysed laboratory data from all viral respiratory reverse transcription quantitative polymerase chain reaction (RT-qPCR) diagnostic tests conducted at New South Wales (NSW) Health Pathology in the South Eastern Sydney and Illawarra Health Service from 2018 to 2024. Panel and descriptive analyses were used to report annual RSV testing and detection by age group, care setting, and co-infection with other respiratory viruses using Stata v.18. Of 370,126 unique episodes tested for RSV, there were 13,293 (3.6%) detections. Public health measures for COVID-19 significantly impacted RSV circulation in 2020, with detections nearly absent in the winter season (June-August) and an off-season epidemic occurring in the summer. Annual testing and detection peaked in 2022 and was considerably higher than in pre-pandemic years (testing 6.3-fold and detection 3.4-fold higher than in 2019, respectively). Across the study period, incidence was highest in children aged <5 years (1,613 per 100,000 population). Among older adults (≥60 years of age), prevalence was 125 per 100,000. Testing was primarily performed in outpatients (71%), of which emergency departments were the most frequent care setting (49%). Of all detections, 2,713 (20.4%) had co-infections, with the most commonly co-detected viruses being rhinovirus (37%) and bocavirus (17%). RSV testing increased from 2022 due to expanded respiratory screening, RSV becoming a notifiable disease, and COVID-19 epidemics. Multiplex RT-qPCR testing increased RSV detection, but testing bias exists, with children tested more than adults. Continued surveillance across age groups is essential to assess the impact of new immunisation strategies.</p>\",\"PeriodicalId\":19915,\"journal\":{\"name\":\"Pathology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.pathol.2025.06.011\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.pathol.2025.06.011","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

鉴于最近在诊断检测、COVID-19干预措施和老年人认知不足方面取得的进展,澳大利亚呼吸道合胞病毒(RSV)的流行病学尚不清楚。需要数据来为新的RSV疫苗使用提供信息。我们分析了2018年至2024年在悉尼东南部新南威尔士州(NSW)健康病理学和伊拉瓦拉健康服务中心进行的所有病毒呼吸逆转录定量聚合酶链反应(RT-qPCR)诊断测试的实验室数据。使用Stata v.18进行小组分析和描述性分析,报告按年龄组、护理环境和合并感染其他呼吸道病毒进行年度RSV检测和检测。在37万126例RSV检测中,有13万293例(3.6%)被检测到。针对COVID-19的公共卫生措施在2020年显著影响了RSV的传播,冬季(6月至8月)几乎没有检测到RSV,而夏季出现了淡季流行。年度检测和检出率在2022年达到峰值,远高于大流行前的年份(检测率和检出率分别比2019年高6.3倍和3.4倍)。在整个研究期间,老年儿童的发病率最高
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epidemiology of respiratory syncytial virus within a New South Wales-based multi-centre health district between 2018 and 2024 in Australia.

Respiratory syncytial virus (RSV) epidemiology in Australia is unclear given recent advances in diagnostic testing, COVID-19 interventions, and under-recognition in older adults. Data are needed to inform new RSV vaccine use. We analysed laboratory data from all viral respiratory reverse transcription quantitative polymerase chain reaction (RT-qPCR) diagnostic tests conducted at New South Wales (NSW) Health Pathology in the South Eastern Sydney and Illawarra Health Service from 2018 to 2024. Panel and descriptive analyses were used to report annual RSV testing and detection by age group, care setting, and co-infection with other respiratory viruses using Stata v.18. Of 370,126 unique episodes tested for RSV, there were 13,293 (3.6%) detections. Public health measures for COVID-19 significantly impacted RSV circulation in 2020, with detections nearly absent in the winter season (June-August) and an off-season epidemic occurring in the summer. Annual testing and detection peaked in 2022 and was considerably higher than in pre-pandemic years (testing 6.3-fold and detection 3.4-fold higher than in 2019, respectively). Across the study period, incidence was highest in children aged <5 years (1,613 per 100,000 population). Among older adults (≥60 years of age), prevalence was 125 per 100,000. Testing was primarily performed in outpatients (71%), of which emergency departments were the most frequent care setting (49%). Of all detections, 2,713 (20.4%) had co-infections, with the most commonly co-detected viruses being rhinovirus (37%) and bocavirus (17%). RSV testing increased from 2022 due to expanded respiratory screening, RSV becoming a notifiable disease, and COVID-19 epidemics. Multiplex RT-qPCR testing increased RSV detection, but testing bias exists, with children tested more than adults. Continued surveillance across age groups is essential to assess the impact of new immunisation strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pathology
Pathology 医学-病理学
CiteScore
6.50
自引率
2.20%
发文量
459
审稿时长
54 days
期刊介绍: Published by Elsevier from 2016 Pathology is the official journal of the Royal College of Pathologists of Australasia (RCPA). It is committed to publishing peer-reviewed, original articles related to the science of pathology in its broadest sense, including anatomical pathology, chemical pathology and biochemistry, cytopathology, experimental pathology, forensic pathology and morbid anatomy, genetics, haematology, immunology and immunopathology, microbiology and molecular pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信